✦ LIBER ✦

Hemiplegia as a complication of treatment of childhood immune thrombocytopenic purpura with intravenously administered immunoglobulin

✍ Scribed by John Tsiouris; Nick Tsiouris

Book ID: 117166063
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 621 KB
Volume: 133
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(98)70131-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neurologic complications of treatment of

Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G

✍ Antonios C. Kattamis; Sadhna Shankar; Alan R. Cohen 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Treatment of chronic childhood immune th

Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins

✍ Caterina Borgna-Pignatti; Laura Battisti; Marco Zecca; Franco Locatelli 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Comparison of intravenous immunoglobulin

Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura

✍ Şinasi Özsoylu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Comparison of intravenous immunoglobulin

Comparison of intravenous immunoglobulin and high dose anti-D immunoglobulin as initial therapy for childhood immune thrombocytopenic purpura: response Özsoylu

✍ Ian Kane; Ram Kalpatthi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

Safety and tolerability of a novel chrom

Safety and tolerability of a novel chromatography-based intravenous immunoglobulin when administered at a high infusion rate in patients with immune thrombocytopenic purpura

✍ James B. Bussel; Kim Hanna 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 2 views

## Abstract Intravenous immunoglobulin (IGIV) therapy is generally considered to be a safe and effective treatment for idiopathic thrombocytopenic purpura (ITP). The usual initial treatment dose is 1–2 g/kg body weight, which results in an extended infusion time, significantly impacting patients' d

Portal vein thrombosis as complication o

Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura

✍ Georg Dultz; Bernd Kronenberger; Alireza Azizi; Ulrike Mihm; Thomas J. Vogl; Ulr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 803 KB